Psychedelics IP Protection: Cybin Nabs US Patent For Deuterated Analogs, Psilera Advances Next-Gen Library - Cybin (AMEX:CYBN)
Cybin’s New US Patent Covers Proprietary Deuterated Psychedelic Analogs
Source: benzinga.com
Psilera Third Eye News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Psilera Third Eye. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Psilera Third Eye Today - Breaking & Trending Today
Psilera Eyes Non-Hallucinogenic Drug Candidates for First-in-Human Studies
/PRNewswire/ -- Psilera is proud to achieve a landmark preclinical milestone with 100% success. Its first cohort of drug candidates designed and synthesized...
Source: prnewswire.com
Psilera to Present on International Stage at Biotech Showcase in San Francisco January 9th -11th, 2023
/PRNewswire/ -- Psilera is proud to be an invited presenter at the Biotech Showcase of 2023 in San Francisco, CA. This prestigious event surrounding the JP...
Source: prnewswire.com
Psilera's Award-Winning Co-Founders To Be Featured Speakers at Upcoming Industry Conferences Across the Country.
/PRNewswire/ -- The 5th Annual Neuropsychiatric and Psychedelics Drug Development Summit will be held in Boston, MA from October 31st to November 2nd. Dr....
Source: prnewswire.com
Psilera Receives First Patent Allowance for Transdermal Patch Formulations
/PRNewswire/ -- Psilera Inc. ("Psilera"), a biopharmaceutical company optimizing next-generation mental health treatments, announces the patent approval of...
Source: prnewswire.com